Key result
Conventional cardiovascular risk factors fail to predict elevated cardiac biomarkers in younger adults with chest pain.
Why the study?
The role of gender in shaping cardiovascular risk and biomarker expression among younger populations presenting with chest pain is less clear.
Cross-Sectional (n=100)
No
In young and middle-aged adults presenting with chest pain, elevated cardiac biomarkers showed wide inter-individual variability but were independent of gender and traditional cardiovascular risk factors.
Answers are grounded in this paper and cite their sources.
Biomarker thresholds in young adults with chest pain need no gender- or risk-specific adjustment; leaves open etiology and requires prospective validation.
Background: Cardiovascular disease remains the leading global cause of morbidity and mortality. Although conventional risk factors are well established, the role of gender in shaping cardiovascular risk and biomarker expression among younger populations is less clear. Objective: This study aimed to evaluate gender-based associations of conventional cardiovascular risk factors and cardiac biomarkers in patients presenting with chest pain. Methods: A cross-sectional study was conducted on 100 patients (60 males, 40 females) aged 18–60 years. Demographic data, lifestyle factors, and medical history were recorded. Serum levels of high-sensitivity C-reactive protein, high-sensitivity troponin-I, N-terminal pro–B-type natriuretic peptide, creatine phosphokinase, creatine kinase-MB, and lactate dehydrogenase were measured. Associations between gender, risk factors (physical activity, hypertension, smoking, diabetes mellitus), and biomarker levels were analyzed using chi-square tests. Results: Elevated levels of various biomarkers were observed across participants, with wide inter-individual variability. However, no statistically significant associations were found between gender and biomarker expression (CPK p=0.077, CK-MB p=0.110, LDH p=0.259, hs-cTnI p=0.672, hs-CRP p=0.409, NT-proBNP p=0.539). Similarly, no significant correlations were identified between biomarkers and physical activity, hypertension, smoking, or diabetes mellitus (all p > 0.05). Conclusion: In this study, cardiac biomarker elevations were not significantly influenced by gender or conventional cardiovascular risk factors. These findings suggest that biomarker changes may reflect subclinical myocardial stress or injury beyond the explanatory scope of traditional risk factors
No takes yet. Share an insight, caveat, or question.
Jamil et al. (2025) conducted a cross-sectional in Chest pain (n=100). Gender and conventional cardiovascular risk factors vs. Males vs Females (for gender) was evaluated on Association of gender and risk factors with cardiac biomarker expression (CPK, CK-MB, LDH, hs-cTnI, hs-CRP, NT-proBNP) (p=>0.05). Neither gender nor conventional cardiovascular risk factors were significantly associated with elevations in cardiac biomarkers in young to middle-aged adults presenting with chest pain.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: